ArticleAmerican journal of ophthalmology case reports2025
Acute myeloid leukemia presenting as an isolated orbital mass in an adult.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A case report of multifocal gastrointestinal myeloid sarcoma without leukemic involvement: an unusual presentation posing a diagnostic challenge.Leukemia research reports · 2026Article
- Atypical orbital mass as the precursor for myelodysplastic syndrome recurrence: a case report.American journal of ophthalmology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Myeloid sarcoma (MS) is an extramedullary-based hematolymphoid tumor that presents in 2-9 % of cases of acute myeloid leukemia (AML). Observations: A 61-year-old man presented with several weeks of unilateral eye pain, proptosis, and diplopia. Examination demonstrated 4 mm of proptosis with limitation of supraduction and abduction. Presenting visual acuity was 20/50 with no signs of optic neuropathy. Imaging revealed an infiltrative, retrobulbar soft tissue density involving the extraocular muscles and optic nerve. Laboratory workup for inflammatory and infectious etiologies was negative. The patient initially responded well to a high-dose oral steroid taper but developed recurrent symptoms. Biopsy was pursued and histopathology was consistent with MS, conferring a diagnosis of AML. Oncologic workup demonstrated central nervous system involvement. After orbital radiation and chemotherapy, no further blasts were detectable in the cerebral spinal fluid. At one year follow-up the patient had complete clinical tumor regression, with stable visual acuity and resolved right exophthalmos. Conclusions and importance: In adults, MS presents rarely as an isolated finding in the orbit. Biopsy is indicated when an orbital mass recurs or does not fully respond to anti-inflammatory treatment. Establishing a diagnosis of MS can be a histopathological challenge. Genetic testing to evaluate for CEBPA mutations in the bZIP domain can predict a good prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.